Evidence map›Paper›PMID 28445471›Full record

ArticlePloS one2017

A randomized trial comparing concise and standard consent forms in the START trial.

Christine Grady, Giota Touloumi, A Sarah Walker, Mary Smolskis, Shweta Sharma, Abdel G Babiker, Nikos Pantazis, Jorge Tavel, Eric Florence, Adriana Sanchez and 7 more

Registry-linked trialAbstract read
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00867048 (Strategic Timing of AntiRetroviral Treatment), which is not on this map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00867048 phase4completednot on this map

Strategic Timing of AntiRetroviral Treatment

TypeinterventionalSponsorUniversity of MinnesotaRan2009 to 2022Enrolled4,688ConditionsHIV InfectionArmsAll licensed antiretroviral medications
3 · Its place in the literature

Who cites it

24 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Article
  8. Article
  9. Article
  10. Observational
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Readability of consent forms in veterinary clinical research.Journal of veterinary internal medicine · 2019
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Christine GradyDepartment of Bioethics, NIH Clinical Center, Bethesda, Maryland, United States of America.ORCID http://orcid.org/0000-0002-9093-4450
Giota TouloumiDepartment of Hygiene, Epidemiology & Medical Statistics, Medical School, National & Kapodistrian University of Athens, Athens, Greece.
A Sarah WalkerMRC Clinical Trials Unit at University College London, London, United Kingdom.
Mary SmolskisNIAID Division of Clinical Research, NIH, Bethesda, Maryland, United States of America.
Shweta SharmaDivision of Biostatistics, University of Minnesota, Minneapolis, Minnesota, United States of America.
Abdel G BabikerMRC Clinical Trials Unit at University College London, London, United Kingdom.
Nikos PantazisDepartment of Hygiene, Epidemiology & Medical Statistics, Medical School, National & Kapodistrian University of Athens, Athens, Greece.
Jorge TavelGenentech Research and Early Development, South San Francisco, California, United States of America.
Eric FlorenceDepartment of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.
Adriana SanchezWashington ICC and Terry Beirn CPCRA CTU, Washington VA Medical Center, Washington DC, United States of America.
Fleur HudsonMRC Clinical Trials Unit at University College London, London, United Kingdom.
Antonios PapadopoulosForth Department of Internal Medicine, Medical School, National & Kapodistrian University of Athens, Athens, Greece.
Ezekiel EmanuelDepartment of Medical Ethics and Health Policy, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.
Megan ClewettUniversity of New South Wales, Sydney, Australia.
David MunroeSTART Community Advisory Board (CAB), University of Minnesota, Minneapolis, Minnesota, United States of America.
Eileen DenningDivision of Biostatistics, University of Minnesota, Minneapolis, Minnesota, United States of America.
INSIGHT START Informed Consent Substudy Group

Funding

International Network for Strategic Initiatives in Global HIV Trials (INSIGHT)UM1AI068641 · NIAID · UNIVERSITY OF MINNESOTA · PI NEATON, JAMES DENNIS · 2011 to 2014
$83.5M
International Network for Strategic Initiatives in Global HIV Trials (INSIGHT): STARTUM1AI120197 · NIAID · UNIVERSITY OF MINNESOTA · PI NEATON, JAMES DENNIS · 2015 to 2017
$65.1M
Randomized informed consentZIACL010531 · CLC · CLINICAL CENTER · PI GRADY, CHRISTINE P · 2009 to 2022
$0k
Medical Research Council MC_EX_UU_G0800814Medical Research Council MC_UU_12023/23Medical Research Council MC_UU_12023/24NIAID NIH HHS UM1 AI068641NIAID NIH HHS UM1 AI120197
6 · The paper itself

Abstract

backgroundImproving the effectiveness and efficiency of research informed consent is a high priority. Some express concern about longer, more complex, written consent forms creating barriers to participant understanding. A recent meta-analysis concluded that randomized comparisons were needed.

methodsWe conducted a cluster-randomized non-inferiority comparison of a standard versus concise consent form within a multinational trial studying the timing of starting antiretroviral therapy in HIV+ adults (START). Interested sites were randomized to standard or concise consent forms for all individuals signing START consent. Participants completed a survey measuring comprehension of study information and satisfaction with the consent process. Site personnel reported usual site consent practices. The primary outcome was comprehension of the purpose of randomization (pre-specified 7.5% non-inferiority margin).

results77 sites (2429 participants) were randomly allocated to use standard consent and 77 sites (2000 participants) concise consent, for an evaluable cohort of 4229. Site and participant characteristics were similar for the two groups. The concise consent was non-inferior to the standard consent on comprehension of randomization (80.2% versus 82%, site adjusted difference: 0.75% (95% CI -3.8%, +5.2%)); and the two groups did not differ significantly on total comprehension score, satisfaction, or voluntariness (p>0.1). Certain independent factors, such as education, influenced comprehension and satisfaction but not differences between consent groups.

conclusionsAn easier to read, more concise consent form neither hindered nor improved comprehension of study information nor satisfaction with the consent process among a large number of participants. This supports continued efforts to make consent forms more efficient.

trial registrationInformed consent substudy was registered as part of START study in clinicaltrials.gov #NCT00867048, and EudraCT # 2008-006439-12.

Indexed as

Informed ConsentAdultAnti-Retroviral AgentsComprehensionFemaleHealth ServicesHIV InfectionsHumansMaleMiddle AgedOdds RatioPatient SatisfactionRandomized Controlled Trials as TopicSurveys and QuestionnairesAnti-Retroviral Agents

Identifiers

PMID28445471
PMCPMC5406127

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.